These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 22335459)

  • 21. Genetic polymorphisms of NAT2, CYP2E1 and GST enzymes and the occurrence of antituberculosis drug-induced hepatitis in Brazilian TB patients.
    Teixeira RL; Morato RG; Cabello PH; Muniz LM; Moreira Ada S; Kritski AL; Mello FC; Suffys PN; Miranda AB; Santos AR
    Mem Inst Oswaldo Cruz; 2011 Sep; 106(6):716-24. PubMed ID: 22012226
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of polymorphic N-acetyl transferase2 and cytochrome P4502E1 gene in antituberculosis treatment-induced hepatitis.
    Bose PD; Sarma MP; Medhi S; Das BC; Husain SA; Kar P
    J Gastroenterol Hepatol; 2011 Feb; 26(2):312-8. PubMed ID: 21261721
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NAT2 and CYP2E1 polymorphisms associated with antituberculosis drug-induced hepatotoxicity in Chinese patients.
    An HR; Wu XQ; Wang ZY; Zhang JX; Liang Y
    Clin Exp Pharmacol Physiol; 2012 Jun; 39(6):535-43. PubMed ID: 22506592
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic interaction between NAT2, GSTM1, GSTT1, CYP2E1, and environmental factors is associated with adverse reactions to anti-tuberculosis drugs.
    Costa GN; Magno LA; Santana CV; Konstantinovas C; Saito ST; Machado M; Di Pietro G; Bastos-Rodrigues L; Miranda DM; De Marco LA; Romano-Silva MA; Rios-Santos F
    Mol Diagn Ther; 2012 Aug; 16(4):241-50. PubMed ID: 22788240
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interleukin-4 and interleukin-10 polymorphisms and antituberculosis drug-induced hepatotoxicity in Chinese population.
    Wang J; Chen R; Tang S; Lv X; Wu S; Zhang Y; Yang Z; Xia Y; Chen D; Zhan S
    J Clin Pharm Ther; 2015 Apr; 40(2):186-91. PubMed ID: 25308608
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The association between BACH1 polymorphisms and anti-tuberculosis drug-induced hepatotoxicity in a Chinese cohort.
    Zhang H; Qian H; Tao B; Yang M; Gong J; Yi H; Tang S
    Infect Genet Evol; 2018 Dec; 66():217-221. PubMed ID: 30316884
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of GSTM1, GSTT1 and GSTP1 gene polymorphism and risk of ARV-associated hepatotoxicity in HIV-infected individuals and its modulation.
    Singh HO; Lata S; Angadi M; Bapat S; Pawar J; Nema V; Ghate MV; Sahay S; Gangakhedkar RR
    Pharmacogenomics J; 2017 Jan; 17(1):53-60. PubMed ID: 26667829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined analysis of germline polymorphisms of p53, GSTM1, GSTT1, CYP1A1, and CYP2E1: relation to the incidence rate of cervical carcinoma.
    Kim JW; Lee CG; Park YG; Kim KS; Kim IK; Sohn YW; Min HK; Lee JM; Namkoong SE
    Cancer; 2000 May; 88(9):2082-91. PubMed ID: 10813720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The roles of GSTM1 and GSTT1 null genotypes and other predictors in anti-tuberculosis drug-induced liver injury.
    Monteiro TP; El-Jaick KB; Jeovanio-Silva AL; Brasil PE; Costa MJ; Rolla VC; de Castro L
    J Clin Pharm Ther; 2012 Dec; 37(6):712-8. PubMed ID: 22845549
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased risk of antituberculosis drug-induced hepatotoxicity in individuals with glutathione S-transferase M1 'null' mutation.
    Roy B; Chowdhury A; Kundu S; Santra A; Dey B; Chakraborty M; Majumder PP
    J Gastroenterol Hepatol; 2001 Sep; 16(9):1033-7. PubMed ID: 11595069
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors of isoniazid-induced hepatotoxicity in Tunisian tuberculosis patients.
    Ben Fredj N; Gam R; Kerkni E; Chaabane A; Chadly Z; Boughattas N; Aouam K
    Pharmacogenomics J; 2017 Jul; 17(4):372-377. PubMed ID: 27089936
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of glutathione S-transferase M1 and T1 homozygous null mutations on the risk of antituberculosis drug-induced hepatotoxicity in a Caucasian population.
    Leiro V; Fernández-Villar A; Valverde D; Constenla L; Vázquez R; Piñeiro L; González-Quintela A
    Liver Int; 2008 Jul; 28(6):835-9. PubMed ID: 18397238
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship of NAT2, CYP2E1 and GSTM1/GSTT1 polymorphisms with mild elevation of liver enzymes in Brazilian individuals under anti-tuberculosis drug therapy.
    Forestiero FJ; Cecon L; Hirata MH; de Melo FF; Cardoso RF; Cerda A; Hirata RD
    Clin Chim Acta; 2013 Jan; 415():215-9. PubMed ID: 23099118
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacogenetic study of drug-metabolising enzyme polymorphisms on the risk of anti-tuberculosis drug-induced liver injury: a meta-analysis.
    Cai Y; Yi J; Zhou C; Shen X
    PLoS One; 2012; 7(10):e47769. PubMed ID: 23082213
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Association of P450-2E1 and GSTM1 genetic polymorphisms with susceptibility to antituberculosis drug-induced hepatotoxicity].
    Wang T; Wang W; Wang ZY; Pan YY; Su QQ; He LX
    Zhonghua Jie He He Hu Xi Za Zhi; 2009 Aug; 32(8):585-7. PubMed ID: 19958676
    [TBL] [Abstract][Full Text] [Related]  

  • 36. N-acetyltransferase and cytochrome P450 2E1 gene polymorphisms and susceptibility to antituberculosis drug hepatotoxicity in an Indian population.
    Mishra S; Daschakraborty S; Shukla P; Kapoor P; Aggarwal R
    Natl Med J India; 2013; 26(5):260-5. PubMed ID: 25017831
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of gene-gene and gene-environment interactions associated with antituberculosis drug-induced hepatotoxicity.
    Chamorro JG; Castagnino JP; Aidar O; Musella RM; Frías A; Visca M; Nogueras M; Costa L; Perez A; Caradonna F; de Larrañaga GF
    Pharmacogenet Genomics; 2017 Oct; 27(10):363-371. PubMed ID: 28799976
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GSTM1 and GSTT1 genetic polymorphisms and risk of anti-tuberculosis drug-induced hepatotoxicity: an updated meta-analysis.
    Li C; Long J; Hu X; Zhou Y
    Eur J Clin Microbiol Infect Dis; 2013 Jul; 32(7):859-68. PubMed ID: 23377313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CYP7A1, BAAT and UGT1A1 polymorphisms and susceptibility to anti-tuberculosis drug-induced hepatotoxicity.
    Chen R; Wang J; Tang SW; Zhang Y; Lv XZ; Wu SS; Yang ZR; Xia YY; Chen DF; Zhan SY
    Int J Tuberc Lung Dis; 2016 Jun; 20(6):812-8. PubMed ID: 27155186
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of GST null genotypes with anti-tuberculosis drug induced hepatotoxicity in Western Indian population.
    Gupta VH; Singh M; Amarapurkar DN; Sasi P; Joshi JM; Baijal R; H R PK; Amarapurkar AD; Joshi K; Wangikar PP
    Ann Hepatol; 2013; 12(6):959-65. PubMed ID: 24114827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.